RESOLVE to do better
British Journal of Haematology · 2026-11 · 209 (5) · 2389-2391
DOI: 10.1111/bjh.70857 ↗Kurz gefasst
Kommentar in der Zeitschrift British Journal of Haematology, online erschienen am 27.09.2026. Verfasst von Jane A Little. Beteiligte Einrichtung: Adult Sickle Cell Disease Clinic at University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Leg Ulcer. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Commentary on: Long Title: Phase 3, randomised, placebo‐controlled trial of Voxelotor for the resolution of leg ulcers in sickle cell disease: RESOLVE. Br J Haematol. 2026;209:2252–2263.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Adult Sickle Cell Disease Clinic at University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.
- UNC Blood Research Center, Chapel Hill, North Carolina, USA.
ORCID-Profile: Jane A Little
Zitieren
APA
Little, J. A. (2026). RESOLVE to do better. British Journal of Haematology, 209(5), 2389-2391. https://doi.org/10.1111/bjh.70857
Vancouver
Little JA. RESOLVE to do better. British Journal of Haematology. 2026;209(5):2389-2391. doi:10.1111/bjh.70857
BibTeX
@article{Little2026,
author = {Little, Jane A},
title = {RESOLVE to do better},
journal = {British Journal of Haematology},
year = {2026},
volume = {209},
number = {5},
pages = {2389--2391},
doi = {10.1111/bjh.70857}
}
EUVIMED